Human serous-type ovarian tumors contain an acidic isoenzyme of amylase. Previous attempts at purification of tumor amylases have yielded preparations contaminated with other proteins. The purification scheme presented here incorporates an affinity-chromatography procedure, with use of cycloheptaamylose linked to epoxy-activated Sepharose, that is specific for cr-amylase (EC 3.2.1.1). Purified amylase isoenzyme from a human serous ovarian tumor was characterized and compared with the purified salivary and pancreatic isoenzymes. All three were similar in amino acid composition, pH optimum, substrate specificity, calcium requirement, heat inactivation, and l for maltotetraose substrate. The ovarian tumor amylase was similar to the salivary and distinct from the pancreatic enzyme by apparent molecular mass and doublet formation on sodium dodecyl sulfate-polyacrylamide electrophoresis, specific activity of pure enzyme, and sensitivity to specific a-amylase inhibitors. All three isoenzymes differed in net electrical charge as evidenced by diethylaminoethyl-Sephadex ion-exchange chromatography and isoelectric focusing. The tumor amylase is clearly distinct from the pancreatic and differs from the salivary enzyme in net electrical charge. Evidence is presented tl1at this charge' difference may reflect, at least in part, deamidation of an amylase that is similar to or identical with salivary amylase.
As is well known, a-amylase (EC 3.2.1.1) in humans occurs in two isoenzymic forms, the pancreatic type and the salivary type, and most of the extensive investigations of human amylases have involved these two forms (for reviews, see 1, 2). We recently found that cyst fluids from human serous ovarian tumors contain high amylase activity (3). This finding is a unique and consistent feature of the serous type of ovarian tumor, as demonstrated by measurements of amylase in ovarian tumor cyst fluids (3,4) and by immunohistochemical staining of amylase in ovarian tumor epithelia (5) . The discovery of a distinctive amylase isoenzyme as a potential tumor marker is important because ovarian cancer is a leading cause of death among gynecologic malignancies; among ovarian cancers, the serous type is the most common (6) .
Amylases from human tumors have been only partly characterized (7-12). The previously reported pure preparation (13) appears to have been heavily contaminated with other proteins (see below). Our initial characterization of the amylase from human serous ovarian cyst fluids showed this enzyme to be distinguishable from pancreatic and salivary amylases by its acidic net charge on diethylaminoethyl (DEAE)-Sephadex ion-exchange chromatography and isoelectric focusing (3, 4)2 Subsequent work led us to develop a DEAE-Sephadex mini-column procedure, which could be used to quickly determine this acidic ovarian tumor amylase in cyst fluids (4) . The desire to explore the potential utility of ovarian tumor amylase as a serum tumor marker and to search for further distinguishing features of this amylase led us to the studies reported here on the purification and characterization of the ovarian tumor amylase and the direct comparison of this enzyme with purified human salivary and pancreatic amylases.
Materials and Methods

Materials
Cyst fluids, obtained from human serous ovarian tumors within an hour of surgical removal, were centrifuged at 3000 x g for 10 nun to remove debris and frozen at -70 #{176}C until assay or purification.
Whole saliva was obtained from one individual, diluted with an equal volume of isotonic saline to reduce viscosity, and centrifuged at 4000 x g for 30 nun to remove debris.
Human pancreases were obtained at autopsy within 12 h of the estimated time of death, trimmed of visible fat and ducts, and homogenized for 60 s in a Sorvall Omni-Mixer (Du Pont Instruments, Newtown, CT 06470) with a pH 7.0 buffer containing, per liter, 320 mg of phenylmethylsulfonyl fluoride, 10 g of aprotimn (Trasylol), 50 mmol of f3-glycerophosphate, and 150 mmol of NaC1. strates as indicated below. In this method, 0.5-mL samples of amylase in a pH 6.9 solution containing, per liter, 20 mmol of PIPES, 6 mmol of NaCl, and 0.5 mmol of CaCl2, were mixed with 0.5 mL of substrate solution in this same buffer and incubated at 22 #{176}C. Aliquots of 0.25 mL were taken at three intervals as selected from the linear portion of the reaction curve, mixed with 0.25 mL of dinitrosalicylic acid reagent, boiled for 5 mm, mixed with 0.5 mL of water, and measured for absorbance at 540 nm. We used standard curves prepared by use of maltose to determine enzyme activity from absorbance data. We avoided the dmnitrosalicylic acid method for amylase assays with maltose and maltotriose as substrates because of the high concentration of reducing groups in these substrates.
For assay with these substrates we used the enzymic (hexokinase, EC 2.7.1.1) method for specific measurement of glucose production.
We removed 0.1-mL aliquota from the assay mixtures, boiled them for 5 mm to stop the enzymic reaction, and determined the micromoles of glucose released per minute.
One unit (U) of enzyme activity by the coupled enzymic method with maltotetraose substrate is defined as 1 mol of NADH generated per minute; the dinitrosalicylic acid assay results were expressed as micromoles of reducing groups generated per minute.
Determinations of substrate specificity were performed at final concentrations of 5 g of corn or potato starch, 2.5 mmol of maltopentaose or maltotetraose, or 19 mmol of maltose or maltotriose per liter. All starches were acid-treated before use (16). Production of sugars was monitored with the dinitrosalicylic acid procedure, except when maltose and maltotriose substrates were used, as discussed above.
We determined the Km for maltotetraose substrate by the standard kinetic assay for the ovarian, pancreatic, and salivary isoenzymes, using at least 10 substrate concentrations in the range 0 to 20 mmolJL.
To determine amylase activity as a function of pH, we used the dinitrosalicylic acid method and buffer containing, per liter, 20 mmol of sodium acetate, 20 mmol of NaH2PO4, 20 mmol of Tris, and 6 mmol of NaCl. The buffer was adjusted to 10 pH values within the range 4 to 9 by addition of either acetic acid or sodium hydroxide.
The substrate was aS g/L solution of potato starch in the final assay mixture.
The calcium requirement for amylase activity was examined by use of the dinitrosalicylic acid method with potato starch (5 g/L) as substrate in a pH 6.9 buffer containing, per liter, 20 mmol of PIPES, 6 mmol of NaCl, and either 0.5 mmol of CaC12 or 5 mmol of EGTA. Enzyme solutions (2 g/L) were incubated in the presence of Ca or EGTA for 20 mm at 22 #{176}C before amylase activity was measured.
For heat-inactivation studies, samples of each isoenzyme were incubated at 55 #{176}C in a pH 6.9 solution containing 50 mmol of NaH2PO4 and 50 mmol of NaCl per liter. Aliquots taken at appropriate intervals were cooled on ice and assayed for residual amylase activity by the kinetic assay (14).
Purification.
All purification steps were carried out in a cold room at 4#{176}C. For ammomum sulfate precipitation of the ovarian tumor fluid and saliva samples, we added 277 mg of ammonium sulfate per milliliter of sample (45% saturation).
Samples were incubated for 2 h in the cold and then centrifuged at 5000 x g for 30 mm; the supernatant fluids were discarded and the pellets were redissolved in a pH 7.0 solution containing 50 mmol of /3-glycerophosphate and 150 mmol of NaC1 per liter. The homogenized pancreas sample was not precipitated with ammonium sulfate, because preliminary experiments showed that this did not enhance the specific activity of the amylase from pancreas.
Size exclusion chromatography was performed in a 2.5 x 62 cm column of Bio-Gel A-0.5m, equilibrated in the aforementioned pH 7.0 mixture. The effluent was monitored with an on-line ultraviolet detector at 280 nm, and 7-mL fractions were collected and assayed for amylase activity. Appropriate fractions containing amylase activity were pooled and concentrated with a CX-10 immersible filter (Millipore Corp., Bedford, MA 01730).
CHA-Sepharose was prepared by linking cycloheptaamylose to epoxy-activated Sepharose 6B (17) . Samples were applied to a 0.9 x 12 cm column of the afilnity gel equilibrated in a solution containing 50 mmol of NaH2PO4 and 50 mmol of NaCl per liter, pH 6.9. The column was washed with this buffer until the on-line monitor showed a return of the A2ec to baseline. a-Amylases were then eluted with an 8 g/L solution of CHA in equilibration buffer, 2-mL fractions being collected and assayed for aniylase activity. Appropriate fractions were pooled, concentrated by use of the immersible ifiter, and dialyzed against the pH 6.9 buffer to remove CHA.
Amino acid analysis.
We derivatized 250-pg portions of amylase with iodoacetamide (18), then extensively dialyzed them against the pH 6.9 buffer. After hydrolysis in hydrolysis tubes, samples were evaporated to dryness under N2 for 
Ion-exchange chromatography.
Columns (1.5 x 26 cm) of DEAE-Sephadex were equilibrated in 30 mmol/L Tris, pH 8.5, at 4#{176}C. Samples containing 20 U of purified amylase isoenzyme activity in 0.5 mL of the pH 6.9 buffer were adjusted to pH 8.6 by adding 0.05 mL of 1.5 mol/L Tris, pH 8.8. We used gradients from 0 to 0.5 mol/L NaCl (250 mL total gradient volume) to elute bound amylase. This chromatography was performed at 4#{176}C, and 2.5-mL fractions were collected and assayed for amylase activity.
Electrophoresis.
SDS-PAGE was performed
in vertical slab gels (19), the running gels being 125 g/L acrylamide containing 1 g of SDS per liter. Samples containing 5-10 jg of amylase were evaporated, redissolved in 0.03 mL of a pH 6.8 mixture (0.1 mol of dithiothreitol, 20 g of SDS, 200 mL of glycerol, and 25 mniol of Tris per liter, plus bromphenol blue tracking dye), and boiled for 5 mm. After electrophoresis, gels were stained for protein with Coomassie Blue R-250.
For isoelectric focusing we used 0.5 x 12 cm tube gels in the method of Renner et al. (20) , modified by increasing the final concentrations of acrylamide to 60 g/L and of bisacrylamide to 2.4 g/L and decreasing the ammonium persulfate to 2 g/L. Samples were focused at 400 V overnight at 4#{176}C, then either stained for protein (21) or sliced into 1.3-mm segments, which were then incubated overnight at 4 #{176}C in 0.15 mL of 10 mmol/L NaC1 per slice. The resulting eluate was assayed for amylase activity. Isoelectric points were determined by comparison of migration distance with that of concurrently focused standards of cytochrome c, used as isoelectric point markers. We performed two-dimensional gel electrophoresis, using isoelectric focusing in the first dimension as described above. We then placed the tube gel onto a vertical slab of SDS-PAGE, of the same composition as noted above, and bonded the two gels together with a warm solution containing, per liter, 10 g of agarose, 100 g of glycerol, lOg of SDS, 0.1 mol of dithiothreitol, 0.125 mol of Tris, pH 6.8, and bromphenol blue tracking dye. Electrophoreals was performed as above and followed by Coomassie Blue protein staining. We diluted 10 of purified ovarian tumor amylase to 0.05 mL with 100 mmol/L Na acetate buffer, pH 5.5, and then added 0.1 U of neuraminidase in 0.5 L of the acetate buffer and incubated at 37 #{176}C for 10 h. A sample without neuraminidase was incubated identically.
We analyzed the samples by isoelectric focusing and staining for protein as described above.
Inhibitors.
Samples of each of the purified amylase isoenzymes were diluted to a final activity of approximately 1000 U/L in buffer containing, per liter, 5 g of bovine serum albumin, 50 mmol of NaH2PO4, and 50 mmol of NaCl, pH 6.9. We then mixed 0.02 mL of the diluted amylase with 0.1 mL of this same buffer containing known concentrations of one of the a-ainylase inhibitors and incubated at 23 #{176}C for 30 mm. Residual amylase activity was then determined by the coupled enzyme kinetic method.
Results
Comparison
of amylases from serous ovarian tumor cyst fluids. We determined the isoelectric points of amylases in ovarian tumor cyst fluids from five patients. All samples showed four major peaks of activity at isoelectric points (mean ± SD) of 4.95 ± 0.03,5. 13 ± 0.03,5.44 ± 0.01, and 5.3 ± 0.04. Other minor bands (<5% of total activity) were present in three of the five samples. Althoughthe relative sizes of the major peaks varied among samples, the presence of these four major activity peaks was consistent among samples.
We chose one cyst fluid for purification and detailed analysis of its amylase because of its large volume and high initial amylase activity.
Purification.
We first used a purification scheme consisting of ammonium sulfate precipitation, size exclusion chromatography, and ion-exchange chromatography. This scheme was similar to that used previously by several other groups to purify amylase (9-11, 22), but we found that the final product was contaminated with human immunoglobulin G, as indicated by Ouchterlony double immunodiffusion plates and by chromatography on protein A-Sepharose. By substituting a CHA-Sepharose affinity column for the DEAE-Sephadex ion-exchange chromatography, we obtained amylase that had no such contamination.
This CHASepharose affinity gel has high loading capacity, and is readily prepared, re-usable, and highly specific for the binding of a-amylases (17) .
The current purification scheme (Table 1 ) required only two column-chromatographic steps. The final specific activities of purified ovarian and salivary amylases were 735 and 753 U/mg, respectively, whereas that of the pancreatic isoenzyme was 416 U/mg. By contrast, the common purifica- 
for the same three enzymes. The final yields of amylase were also significantly greater with the new protocol (63-84%) than with the old (15-30%). We documented the purity of the final amylase preparations by isoelectric focusing and SDS-PAGE (see below). In addition, we found no immunoglobulin contamination, as indicated by the absence of precipitin lines on Ouchterlony double-iminunodiffusion plates against antisera raised against human immunoglobulins G, A, or M or against a polyvalent antiserum.
Amino acid composition.
The amino acid compositions of the three isoenzymes were identical within the analytical error of the procedure ( Table 2 ). The greatest difference for any pair of values was only 0.7 residue per 100 residues, which was less than 1 SD for the assay of that amino acid (Glx, "glutamic acid or glutamine").
SDS-PAGE.
By SDS-PAGE the ovarian tumor and salivary isoenzymes (Figure 1, lanes B and C) appeared identical to each other, both migrating as doublets with apparent relative molecular masses of 57 000 and 60 000. This type of doublet formation is a feature of the salivary isoenzyme and is believed to be caused by differences in glycosidation (22-24). The ovarian tumor isoenzyme appeared similar to the salivary in this regard. The pancreatic isoenzyme ( Figure 1 , lane A) migrated as a single band with an apparent relative molecular mass of 55 000.
Ion-exchange chromatography and isoelectric focusing.
The physical characteristic that most distinguished the ovarian tumor amylase from the pancreatic or salivary isoenzyme was its net electrical charge. Previous work had indicated that significantly greater salt concentrations were necessary for elution of the ovarian tumor isoenzyme from DEAE-Sephadex columns than for the pancreatic or salivary isoenzymes (3, 4). However,, those studies were performed with a discontinuous salt gradient. Repeating this experiment with a continuous salt gradient and, for the first time, purified ovarian tumor amylase, we compared the elution of the ovarian form with that of the purified salivary and pancreatic isoenzymes (Figure 2 ). For DEAE-Sephadex column chromatography, the purified ovarian tumor amylase required greater concentrations of NaCl for elution than did the other two isoenzymes. NaCIgradients of 0 to 500 mmol/Lwereusedto eluteboundamylase than did the other two isoenzymes.
We used isoelectric focusing to characterize the net charge differences among these isoenzymes.
The ovarian tumor isoenzyme showed a multiplicity of protein bands with coincident enzymic activity (Figure 3, A) . The major enzyme activity band had a p1 = 5.45. The pancreatic amylase showed only one band at p1 = 7.4, whereas the salivary isoenzyme showed a doublet with p1 = 6.36 and 6.65 ( Figure  3, B and C) . Most of the multiple bands of the ovarian tumor Gels were ether stainedfor proteinwith CoomassieBlue or sliced,eluted,and testedfor amylase activity ineacheluate amylase were more acidic than even the salivary enzyme. Only the two most basic, and very faint, bands of the ovarian tumor isoenzyme showed isoelectric points similar to those of the salivary enzyme.
These differences in p1 among the three amylase isoenzymes apparently provide the explanation for the differences observed above on DEAE-Sephadex chromatography.
Two-dimensional gel electrophoresis.
For the ovarian tumor and salivary isoenzymes, the multiplicity of protein bands on both SDS-PAGE and isoelectric focusing raised the question of whether these were two methods of looking at the same heterogeneity.
Staining for protein after twodimensional gel electrophoresis indicated that each of the multiple bands of ovarian tumor or salivary amylase seen in the isoelectric focusing dimension consisted of multiple bands. A typical gel pattern for the ovarian tumor amylase is illustrated in Figure 4 . The pattern for the salivary isoenzyme was similar but at the appropriately higher isoelectric points. Therefore, each of the multiple bands seen on isoelectric focusing consisted of the different Mr group- Fig.  3 and then electrophoresedin the second dimension by SOS-PAGE as in Fig. 1 ; stainingwas with CoomassieBlue ings, as seen on SDS-PAGE, and each of the SDS-PAGE bands consisted of several differently charged species.
Neuraminidase treatment.
Increased protein glycosidation by negatively charged neuranunic acid has been postulated for proposed acidic tumor markers such as tumor amylases Therefore, we incubated the ovarian tumor amylase with neuraminidase, to attempt to remove neuraminic acid, and then analyzed this mixture by isoelectric focusing.The p1 value was unchanged from that for a control incubated without neuramiidase (not shown).
Selective inhibition.
Certain amylase inhibitors isolated from plants are known to be much more specific for the human salivary than the human pancreatic isoenzyme (27-29). We tested the inhibitory activity of three such amylase inhibitors on the three purified amylase isoenzymes. Although the three inhibitors varied in the amounts required to produce a given degree of inhibition, the sensitivities of the ovarian tumor and salivary isoenzymes were strikingly similar (see, e.g., Figure 5 ). The pancreatic isoenzyme was consistently less sensitive to the inhibitors than were the other two isoenzymes.
Characterization of enzymic activity.
Plots of amylase activity vs pH for salivary, ovarian, and pancreatic amylases showed symmetrical peaks, with activity maxima at pH 7.0 ± 0.2 (data not shown). Because amylase is a calcium metallo-enzyme (30), we examined the effect of the calcium chelator EGTA on amylase activity. Salivary, ovarian, and pancreatic amylases incubated with EGTA, 5 mmol/L, lost 62, 64, and 62%,respectively, of their activity after incubation with CaCl2, 0.5 mmol/L.
When we compared salivary, ovarian, and pancreatic ainylases with respect to activity towards several substrates, all three isoenzymes showed similar apparent substrate specificities (Table 3) . Maltotetraose, a common substrate in amylase assays, was used for the determination of K,,, by the standard kinetic assay. Lineweaver-Burk and Eadie-Hofstee plots (31) were linear and in close agreement (data not shown). Km values for the three isoenzymes were sum . 1.7, 2.0, and 1.5 mmol/L, respectively, for the ovarian, salivary, and pancreatic amylases. 35% of the original activity remaining after incubation for 90 mm (data not shown).
The presence of high activities of amylase has already been shown to be a consistent feature of cyst fluids from human serous ovarian tumors (3, 7). This ainylase was also shown, in one other patient's sample, to be an acidic isoenzyme, separable from the salivary and pancreatic isoenzymes by DEAE-Sephadex ion-exchange chromatography or isoelectric focusing (3). The analysis we have presented here of the isoelectric focusing patterns of five additional cyst fluid specimens shows that the acidic nature of this amylase is a consistent finding, each sample having similar isoelectric points for four major activity peaks. These observations on the acidic isoenzymes are consistent with our previous data on the uniformly delayed elution from DEAESephadex of amylases from a series of ovarian cyst fluids (4) .
A detailed analysis of the ovarian tumor amylases required purified enzyme as well as purified salivary and pancreatic amylases with which to compare it. Our purification scheme provided final amylase preparations that were free of contamination (by the criteria of purity described in Results).
In our hands, a commonly used purification scheme utilizing ion-exchange instead of affinity chromatography had yielded tumor enzyme that was contaminated by human immunoglobulin G; this type of contamination may be more widespread than is commonly realized. On Bio-Gel A-0.5m size-exclusion chromatography, the trailing edge of the immunoglobulin peak overlapped with the leading edge of the amylase peak (not shown); subsequent ion-exchange chromatography with DEAE-Sephadex did not separate these two proteins. This contamination is not readily apparent on SDS-PAGE because amylase and the heavy chain of CLINICALCHEMISTRY,Vol.30, No. 1, 1984 67 inununoglobulin G have similar relative molecular masses and migrate to approximately the same position on these gels. The previous report (13) on the purification of amylase from human tumors appears to exemplifr this problem. There, the tumor amylase preparations showed low specific activities (<5% of salivary) and low immunoreactivities (<20% of salivary), as compared with the pancreatic and salivary isoenzymes; moreover, the anuno acid compositions, although similar for the three tumor enzymes studied, were quite distinct from the nontumor enzymes, and were essentially identical to the aminoacid composition of human immunoglobulin G. On the basis of these findings and calculations from other data presented by Takeuchi et al. (13), we estimate that only 2-20% of the protein in the tumor amylases preparations they described was amylase. Our use of affinity chromatography on CHA-Sepharose in place of DEAE-Sephadex ion-exchange chromatography appears to avoid this problem.
The purified pancreatic, salivary, and ovarian tumor amylase preparations described herein were found to be essentially identical by five characteristics: amino acid composition, pH optima, loss of activity upon chelation of calcium, substrate specificity, and Michaelis-Menten constaiit (Km) for the maltotetraose substrate. The similarity of purified pancreatic and salivary amylase characteristics is in agreement with the work of others (22, 30,32) .
The pancreatic and salivary isoenzymes are known to be distinct from each other by several criteria, including apparent molecular mass and double-band formation on SDS-PAGE (22), specific activity (22), and inhibition by wheat aamylase inhibitors (27) (28) (29) .
In all of these comparisons we found the ovarian tumor amylase to be similar to or identical with the salivary isoenzyme rather than the pancreatic.
In contrast to previous reports (8, 9, 13, 26) , the only feature distinguishing the ovarian tumor amylase from both the salivary and pancreatic enzymes in the present studies was its met electrical charge, a property shown by both DEAE-Sephadex ion-exchange chromatography and isoelectric focusing. Other tumor markers have been shown to contain neuraminic acid residues, which increase the negative charge on the protein (25, 26). The inability of neuraminidase to alter the isoelectric point of the purified ovarian tumor isoenzyme suggests that sialylation is not the mechanism responsible for its acidic isoelectric point relative to the salivary or pancreatic isoenzymes.
The carbohydrate structure(s) of the tumor amylases are unknown. an increased number of outerchain residues, secretory proteins (e.g., amylase) have had deleted some of the most external residues on the oligosaccharides. However, those studies were based on tumor amylases purified by the procedures of Takeuchi et al. (13), which appear to be heavily contaminated with immunoglobulin G as discussed above. The enzyme samples analyzed for carbohydrate structure, with their low specific activities and low antigenicities, were also probably heavily contaminated with inununoglobulin G. The carbohydrate structures elucidated for this preparation bear striking similarities to those of immunoglobulin G (35). This situation again illustrates the need to document the purity of amylase preparations by a variety of criteria.
The exact biochemical or molecular origin of the ovarian isoenzyme remains unknown. The acidic nature of the tumor amylase might reflect the expression of a distinct amylase gene. Human amylases have been described in a variety of other tissues and fluids, including liver, semen, tears, and milk (1, 36-38 ).
An ainylase has also been described in the endosalpingeal epithelium of the fallopian tube (5, 39, 40 ). This may be related to the ovarian tumor amylase described here, amylase having been shown by immunohistochemical staining to be localized to the endosalpingeal-type epithelium of human serous ovarian tumors (5). The pancreatic and salivary amylases each arise from distinct genetic loci (1), and at least some of these other amylases may be the products of additional loci. Multiple genetic loci are known to occur in other species, e.g., the rat has at least five nonallelic loci for amylase (41).
An alternative explanation of the acidic character of the ovarian tumor amylase involves post-translational modifications of the salivary isoenzyme. The pancreatic and salivary amylases each occur in a number of isoenzymic forms, apparently arising from post-translational modifications involving deamidations and glycosidations (1). The similarities described above between the ovarian tumor amylase and the salivary isoenzyme suggest a possible relationship by just such modifications. Incubations of salivary amylase under conditions chosen to promote deamidations of asparagine and glutamine residues to asparate and glutamate produce enzyme with a p1 similar to that of the ovarian tumor amylase described here (23). In fact, purified salivary amylase incubated under such conditions (pH 9 for one week at 37 #{176}C) then had multiple acidic bands on isoelectric focusing, in a pattern indistinguishable from that for ovarian tumor amylase (Zakowski and Bruns, unpublished observations). We calculated that only three to six deamidations are necessary to produce the observed changes in p1 and that the multiple bands appear to differ by only one net charge unit from each other. Fastidious work will be required to document such a small change in amidation. Thus, deamidation of a salivary-type amylase appears to be a likely explanation for the acidic nature of the ovarian tumor amylase, but direct evidence is lacking and the possibility of a distinct gene for this amylase cannot be excluded.
